| Literature DB >> 32498242 |
Erik Hansson1,2, Jason Glaser2,3, Kristina Jakobsson1,2,4, Ilana Weiss2, Catarina Wesseling2,5, Rebekah A I Lucas2,6, Jason Lee Kai Wei7,8,9, Ulf Ekström2,10, Julia Wijkström11, Theo Bodin5, Richard J Johnson12, David H Wegman2,13.
Abstract
BACKGROUND: Chronic kidney disease of non-traditional origin (CKDnt) is common among Mesoamerican sugarcane workers. Recurrent heat stress and dehydration is a leading hypothesis. Evidence indicate a key role of inflammation.Entities:
Keywords: acute kidney injury; heat; heat stress; hydration; inflammation; kidney; occupation
Mesh:
Substances:
Year: 2020 PMID: 32498242 PMCID: PMC7352879 DOI: 10.3390/nu12061639
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Schematic summary of potential pro-inflammatory stimuli in the sugarcane worker nephron. Red = blood vessels. Yellow = tubular lumen. White boxes = tubulointerstitial cells. RBF = renal blood flow. NSAID = non-steroidal anti-inflammatory drug. SNS = sympathetic nervous system. BF = blood flow. RAAS = renin–angiotensin–aldosterone system. EPO = erythropoietin. Heavy work in heat leads to loss of volume and electrolytes triggering RAAS activation and vasopressin release, reducing renal blood flow, as well as increasing sodium absorption and potassium excretion. Heavy exercise and work decreases renal and gut blood flow through direct competition over the cardiac output and through sympathetic neural pathways. NSAID used to treat musculoskeletal pain from heavy work inhibits afferent arteriolar dilation, further decreasing renal blood flow, while also increasing intestinal permeability. Increased gut permeability enables endotoxins to enter the blood stream and trigger cytokine release systemically and in the tubuli, activating an inflammatory response. This inflammatory response in the tubuli can be further promoted by muscle cell breakdown products such as uric acid and tubular fructose metabolism, which also lead to uric acid production. Inflammation and relative hypoxia in the tubuli cause tubular cell injury, leading to further loss of potassium and decreased EPO synthesis, which in turn further impair tubular oxygen delivery.
Associations between incident kidney injury (IKI) and categorical risk factors among male sugarcane cutters.
| Nicaragua (Adelante Cohort) | El Salvador (IEA Cohort) | |||||||
|---|---|---|---|---|---|---|---|---|
| Worker-Harvests | Worker Follow-up Occasions | |||||||
| Total | IKI | Incidence Ratio (IR) (95% CI) | IR Adjusted for Baseline eGFR (95% CI) | Total | IKI | Odds Ratio (OR) (95% CI) | OR Adjusted for Baseline eGFR (95% CI) | |
| Age (years) | ||||||||
| 18–30 | 320 | 32 (10%) | ref | Ref | 289 | 22 (8%) | Ref | Ref |
| 31–40 | 155 | 16 (10%) | 1.0 (0.6–1.9) | 0.9 (0.5–1.6) | 179 | 32 (18%) | 5.7 (1.3–25) | 1.1 (0.3–3.8) |
| 41–50 | 43 | 5 (12%) | 1.2 (0.5–3.0) | 0.9 (0.3–2.3) | 108 | 20 (19%) | 6.2 (1.1–33) | 0.6 (0.1–2.4) |
| >50 | 14 | 0 (0%) | NA | NA | 108 | 27 (25%) | 17.5 (3.2–95) | 0.8 (0.2–3.1) |
| eGFR, baseline (mL/min/1.73 m2) | ||||||||
| >90 | 358 | 29 (8%) | Ref | Not meaningful | 398 | 16 (4%) | Ref | Not meaningful |
| 90–60 | 163 | 23 (14%) | 1.7 (1.0–3.0) | 136 | 15 (11%) | 5.0 (1.4–18) | ||
| 45–60 | 10 | 1 (10%) | 1.2 (0.2–9.1) | 57 | 19 (33%) | 43 (8.6–211) | ||
| <45 | 1 | 0 (0%) | NA | 85 | 51 (60%) | 290 (51–1663) | ||
| CRP, baseline (mg/L) | ||||||||
| <3 | 423 | 40 (9%) | Ref | Ref | 482 | 69 (14%) | Ref | Ref |
| 3–10 | 85 | 12 (14%) | 1.5 (0.8–2.8) | 1.4 (0.7–2.6) | 153 | 21 (14%) | 1.2 (0.3–4.7) | 0.6 (0.2–1.7) |
| 10–20 | 12 | 0 (0%) | NA | NA | 28 | 10 (36%) | 22 (1.3–384) | 0.9 (0.1–5.8) |
| >20 | 12 | 1 (8%) | 0.9 (0.1–6.4) | 0.7 (0.1–5.4) | 13 | 1 (8%) | 0.3 (0.01–62) | 0.1 (0.01–3.5) |
| CRP, follow-up (mg/L) | ||||||||
| <3 | 340 | 10 (3%) | Ref | Ref | 434 | 25 (6%) | Ref | Ref |
| 3–10 | 142 | 14 (10%) | 3.4 (1.5–7.5) | 3.3 (1.5–7.5) | 173 | 37 (21%) | 8.7 (3.3–23) | 5.0 (1.9–12.9) |
| 10–20 | 24 | 9 (38%) | 13 (5–31) | 13 (5.1–31) | 43 | 21 (49%) | 58 (14–249) | 21 (5.3–82) |
| >20 | 26 | 20 (77%) | 26 (12–56) | 25 (12–54) | 34 | 18 (53%) | 71 (15–337) | 19 (4.7–76) |
| NSAID use at least once per week † | ||||||||
| No | 444 | 37 (8%) | Ref | Ref | 647 | 92 (14%) | Ref | Ref |
| Yes | 88 | 16 (18%) | 2.2 (1.2–3.9) | 2.1 (1.2–3.8) | 25 | 7 (28%) | 2.9 (0.5–16) | 2.8 (0.6–14) |
| Incident fever in past week(s) †† | ||||||||
| No | 463 | 40 (9%) | Ref | Ref | 384 | 41 (11%) | Ref | Ref |
| Yes | 43 | 11 (26%) | 3.0 (1.5–5.8) | 3.1 (1.6–6.1) | 287 | 58 (20%) | 5.6 (1.9–16) | 2.1 (0.9–5.0) |
| Sugary drink intake (L) | Not available | |||||||
| <0.2 | 64 | 2 (3%) | Ref | Ref | ||||
| 0.2–1 | 312 | 30 (10%) | 3.1 (0.7–13) | 3.1 (0.7–13) | ||||
| >1 | 155 | 21 (14%) | 4.3 (1.0–18) | 4.4 (1.0–19) | ||||
| Morning boli intake (N of 300 mL sachets) | ||||||||
| 0 | 125 | 18 (14%) | Ref | Ref | ||||
| 0–3 | 214 | 23 (11%) | 0.7 (0.4–1.4) | 0.8 (0.4–1.5) | ||||
| ≥3 | 180 | 12 (7%) | 0.4 (0.2–0.9) | 0.5 (0.2–0.9) | ||||
| Morning water intake (L) | ||||||||
| 0–2 | 76 | 12 (16%) | Ref | Ref | ||||
| 2–5 | 209 | 18 (9%) | 0.5 (0.3–1.1) | 0.6 (0.3–1.2) | ||||
| >5 | 246 | 23 (9%) | 0.6 (0.3–1.2) | 0.6 (0.3–1.3) | ||||
| Mg, baseline (mmol/L) | ||||||||
| ≥0.7 | Not collected | 455 | 63 (14%) | Ref | Ref | |||
| <0.7 | 67 | 29 (43%) | 22 (3.7–124) | 1.6 (0.4–6.1) | ||||
| K, baseline (mmol/L) | ||||||||
| ≥3.5 | Not collected | 496 | 82 (17%) | Ref | Ref | |||
| <3.5 | 26 | 10 (38%) | 11 (0.9–138) | 5.2 (0.7–38) | ||||
| K, follow-up (mmol/L) | ||||||||
| ≥3.5 | Not collected | 482 | 71 (15%) | Ref | Ref | |||
| <3.5 | 47 | 21 (45%) | 13 (3.1–57) | 7.2 (2.1–25) | ||||
| Na, follow-up (mmol/L) | ||||||||
| ≥137 | 283 | 20 (7%) | Not possible | 153 | 9 (6%) | Not possible | ||
| <137 | 15 | 1 (7%) | 1 | 0 (0%) | ||||
| Incident biochemical changes * | eGFR coefficient (ml/min/1.73 m2) compared to baseline | |||||||
| Hemoglobin <125 g/L | ||||||||
| No | Not collected | 138 | 3 (2%) | Ref | ||||
| Yes | 16 | 3 (19%) | −9 (−12, −5) | |||||
| Dipstick hematuria | ||||||||
| No | Not collected | 105 | 2 (2%) | Ref | ||||
| Yes | 16 | 3 (19%) | −5 (−8, −1) | |||||
| Dipstick proteinuria | ||||||||
| No | Not collected | 141 | 5 (4%) | Ref | ||||
| Yes | 9 | 4 (44%) | −10 (−15, −5) | |||||
| Uric acid crystals | ||||||||
| No | Not collected | 142 | 7 (5%) | Ref | ||||
| Yes | 10 | 2 (20%) | −6 (−11, −1) | |||||
| Non-hyaline cylinders | ||||||||
| No | Not collected | 128 | 6 (5%) | Ref | ||||
| Yes | 9 | 2 (22%) | −7 (−13, −1) | |||||
| Microscopy leukocyturia | ||||||||
| <25/fov | Not collected | 146 | 4 (3%) | Ref | ||||
| ≥25/fov | 7 | 5 (71%) | −26 (−31, −21) | |||||
† In the past two weeks in El Salvador. Missing observations as not all workers have questionnaire data from all visits, year 2 El Salvador. †† One week in year 1 Nicaragua, otherwise two weeks. Not excluding workers with fever at baseline in El Salvador as fever was not asked for. Missing observations as not all workers have questionnaire data from all visits, year 2 El Salvador. * Not present at baseline, excludes workers with the abnormality at baseline or missing data at baseline or follow-up. fov = field of view. Boli = 300 mL electrolyte solution bags containing 7 g of sugar, 50 mg sodium chloride, and 20 mg potassium monophosphate per 100 mL. Cross-harvest: from beginning of harvest (November) until end of harvest (April). Adelante cohort workers may be included in both years [8]. Cross-test interval: From beginning of harvest (November) until one of up to three follow-up visits. IEA cohort workers may be included in both years and have multiple cross-test intervals within one year ([18] and Supplement 1).
Association between incident kidney injury and continuous biochemical parameters in male sugarcane cutters.
| Country | Year | Biochemical parameter | Median (interquartile Range) | Regression coefficients (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
| El Salvador † | Baseline | During harvest | ||||||
| Non IKI day | IKI day | IKI day vs. non IKI day regression coefficient | ||||||
| 1 | Worker-visits | 74 | 145 | 9 | Unadjusted | eGFR-adjusted | ||
| WBC | 109/L | 8.2 (7.2–9.0) | 7.7 (6.6–8.5) | 9.5 (9.3–10) | 2.2 (1.3–3.1) | 1.6 (0.6–2.7) | ||
| Neutrophils | 4.7 (3.9–5.5) | 3.9 (3.3–4.5) | 5.5 (5.3–5.8) | 2.0 (1.3–2.8) | 1.7 (0.8–2.6) | |||
| Lymphocytes | 2.6 (2.2–3.0) | 2.9 (2.5–3.2) | 3.0 (2.7–3.3) | 0.1 (–0.3–0.4) | 0.1 (–0.4–0.5) | |||
| Monocytes | 0.7 (0.6–0.9) | 0.7 (0.5–1.0) | 0.9 (0.8–1.0) | 0.2 (–0.1–0.5) | 0.0 (–0.4–0.3) | |||
| Urine–pH | – | 6 (5.5–6.5) | 6 (5.5–6.5) | 5.5 (5.5–6.0) | –0.4 (–0.8–0.0) | –0.3 (–0.7–0.2) | ||
| Hemoglobin | g/L | 148 (143–153) | 142 (135–148) | 125 (123–130) | –9 (–16––2) | 3 (–4–9) | ||
| Sodium | mmol/L | 141 (139–141) | 140 (139–141) | 140 (139–141) | 0 (–1–1) | 0 (–1–1) | ||
| 1 + 2 | Worker–visits | 345 | 580 | 101 | ||||
| CRP | mg/L | 1.4 (0.7–3.3) | 1.5 (0.7–4.0) | 7.5 (3.0–13) | 7.6 (5.7–9.5) | 3.3 (1.0–5.7) | ||
| Uric acid | mmol/L | 361 (310–443) | 328 (281–389) | 586 (477–672) | 117 (98–135) | 32 (14–50) | ||
| CPK | µkat/L | 2.4 (1.8–3.4) | 2.8 (2.2–3.9) | 3.8 (2.6–5.1) | 0.8 (0.3–1.4) | 0.7 (0.0–1.3) | ||
| 2 | Worker–visits | 213 | 429 | 92 | ||||
| Potassium | mmol/L | 3.9 (3.5–4.1) | 3.9 (3.5–4.2) | 3.4 (3.0–3.9) | –0.3 (–0.5––0.2) | –0.1 (–0.3–0) | ||
| Nicaragua †† | Baseline | At end–harvest | ||||||
| No IKI | IKI | Cross–harvest trend difference between IKI and non–IKI workers | ||||||
| 1 + 2 | Workers | 533 | 480 | 53 | Unadjusted | eGFR–adjusted | ||
| CRP | mg/L | 1.1 (LoQ–2.3) | 1.6 (0.8–3.7) | 12 (5.8–24) | 15 (12–17) | 12 (9–14) | ||
| Uric acid | mmol/L | 324 (277–374) | 326 (282–378) | 428 (345–499) | 61 (47–74) | –5 (–19–9) | ||
| CPK | µkat/L | 2.6 (2.0–3.4) | 3.5 (2.6–4.8) | 3.4 (2.6–5.2) | 0.3 (–0.2–0.8) | 0.0 (–0.6–0.6) | ||
All models were linear mixed models, except CRP in Nicaragua which was modeled using mixed effects tobit regression as results below 0.6 were not quantified. Adjustment for eGFR is for eGFR at the follow-up date. † El Salvador analyses are by worker-visit units, meaning the same individual may have been sampled at up to three occasions during the same harvest, and comparisons in the regression models are between visits during which there was or was not concomitant IKI within that same individual and other individuals, as modeled using a mixed effects model with random effects for individuals. †† Nicaragua analyses are by worker-harvest units as workers were only sampled at baseline and at end of harvest, again modeled with a random effects structure for individuals to account for the repeated measurements within the same worker. CI = confidence interval, WBC = white blood cells, CPK = creatine phosphokinase, CRP = C-reactive protein, LoQ = limit of quantification, for CRP in Nicaragua 0.6 mg/dL, IKI = incident kidney injury, defined as ≥0.3 mg/dL or ≥50% increase in serum creatinine since baseline.